WBA takes 40% stake in China's leading pharmacy chain
Walgreens Boots Alliance on Wednesday extended its retail pharmacy acumen into China by taking a 40% stake in Sinopharm Holding GuoDa Drugstores in a deal worth approximately $416 million.
“We are very pleased to become a strategic investor in GuoDa," stated Stefano Pessina, WBA executive vice chairman and CEO. "It is China’s leading pharmacy chain and we believe that we can positively contribute to its continued successful development with our global pharmacy expertise. We have had a presence in China for around 10 years, initially through Alliance Boots, and we are excited about the opportunity to further invest in the country’s fast growing retail pharmacy sector.”
GuoDa is a leading retail pharmacy chain in China, and has been pursuing its vision for expansion across the country in the context of the ongoing healthcare reforms and increasing importance of the pharmacy channel in the country. Deerfield, Ill.-based Walgreens Boots Alliance, as a global pharmacy-led enterprise, believes it is well positioned to provide its significant expertise to GuoDa and support its growth ambitions.
The transaction is subject to regulatory review and approval, and other customary closing conditions. Upon completion, Walgreens Boots Alliance would account for this stake as an equity method investment.